Header Logo

Connection

ERIC JONASCH to Heptanoic Acids

Back to Details
This is a "connection" page, showing publications ERIC JONASCH has written about Heptanoic Acids.
ERIC JONASCH
Connection Strength
0.025
Heptanoic Acids
  1. Pilot trial of bone-targeted therapy combining zoledronate with fluvastatin or atorvastatin for patients with metastatic renal cell carcinoma. Clin Genitourin Cancer. 2011 Dec; 9(2):81-8.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.